SCHEMBL9865393

SCHEMBL9865393

N=C(NCCCc1c[nH]cn1)NCCSCc1ccc(Cl)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11041744 0.84 ACHE (0.33)
SCHEMBL9868517 0.83 KMT2A (0.42)
SCHEMBL9864976 0.82 KMT2A (0.36)
SCHEMBL9865927 0.82 KDM4E (0.32)
Iodide SCHEMBL10370890 0.82 KMT2A (0.35)
SCHEMBL9876539 0.80 CYP1A2 (0.38)
SCHEMBL7175846 0.79
SCHEMBL9866034 0.79 ALDH1A1 (0.45)
SCHEMBL9865647 0.79 GAA (0.45)
SCHEMBL7175108 0.79 SLC47A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-B1 IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HEUMANN PHARMA GMBH &amp; CO (DE) 1990-08-01 EP disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH &amp; CO (DE) 1986-11-05 EP disclosed